Schinzel-Giedion Syndrome Awarded € 2 000 000
Research grant of over 2 Million Euros ($2.5Million) offers new hope for children with rare condition Schinzel-Giedion Syndrome Contact: Nuala Summerfield Mob: +44 (0)7957 168815 Email: nuala@sgsfoundation.org January 27th 2021; Crawley, West Sussex, UK: Funding from two major European grants has been awarded to an international group of researchers to find treatments for the devastating…
International SGS Awareness Day
International Schinzel-Giedion Syndrome Awareness Day 13 November 2020 By Emma Hudson, Secretary and Trustee of The Schinzel-Giedion Syndrome Foundation and mum to 2-year-old Jude who has SGS Happy Birthday to Us! 13 November 2020 marked one year since the The Schinzel-Giedion Syndrome Foundation was registered as an official charitable organisation with the Charity Commission in…
Recurrence Risk
In this photo: Caroline Recurrence Risk This is a very important question for parents with a child diagnosed with Schinzel-Giedion Syndrome, considering having another child. In this photo: Caroline Recurrence Risk This is a very important question for parents with a child diagnosed with Schinzel-Giedion Syndrome, considering having another child. This information has been written…
Dr. Hans Bjornsson, M.D., Ph.D.
Dr. Hans Bjornsson, M.D., Ph.D.Dr. Bjornsson did his graduate work under the supervision of Andrew P. Feinberg, a leader in the field of epigenetics. He then joined the combined program in pediatrics and human genetics at Johns Hopkins. During his residency training, Dr. Bjornsson worked with Dr. Hal Dietz, a leader in the field of developing therapeutic…
Dr. Rocío Acuña Hidalgo, Ph.D.
Dr. Rocío Acuña Hidalgo, M.D., Ph.D.Rocío Acuña Hidalgo, Ph.D. is a medical doctor and human geneticist based in Berlin, Germany. Her expertise lies in bringing together Next Generation Sequencing (such as exome sequencing) and molecular biology to unravel the molecular mechanisms of mutations that lead to human disease. Rocío completed her Ph.D. at Radboud University Medical Center, where she studied the molecular…
Matthew Burkhardt
Contact Matthew Matthew BurkhardtChair of Advisory BoardMatthew has over 15 years of experience in preclinical target discovery across academic, startup, and industry sectors. He began in traumatic brain injury with the Neurosurgery Department at the University of Pennsylvania, moved into the industry at Merck for in vivo Alzheimer’s Disease small molecule drug discovery and disease…
Newsletter Signup
Sign-up to receive family stories and updates on our research projects and fundraising campaigns.
Select at least one MailChim list.